Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial

被引：0
|
作者：
Hiroaki Seino
机构：
[1] Seino Internal Medical Clinic,
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Hepatic dysfunction; Luseogliflozin; SGLT2 inhibitor; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 877
页数：14
相关论文
共 50 条
  • [1] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Seino, Hiroaki
    DIABETES THERAPY, 2021, 12 (03) : 863 - 877
  • [2] Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
    Hiroaki Seino
    Diabetes Therapy, 2021, 12 : 2807 - 2811
  • [3] Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial (vol 12, pg 863, 2021)
    Seino, Hiroaki
    DIABETES THERAPY, 2021, 12 (10) : 2807 - 2811
  • [4] Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
    Yuxi Chen
    Yuan Pan
    Yanyan Xie
    Yuxun Shi
    Yao Lu
    Yiwen Xia
    Wenru Su
    Xiaoqing Chen
    Zuoyi Li
    Minzhen Wang
    Siyu Miao
    Yating Yang
    Chenjin Jin
    Guangwei Luo
    Shixian Long
    Hui Xiao
    Chuangxin Huang
    Jian Zhang
    Dan Liang
    Signal Transduction and Targeted Therapy, 9 (1)
  • [5] Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study
    Yuriko Hajika
    Yuji Kawaguchi
    Kenji Hamazaki
    Yasuro Kumeda
    Diabetology & Metabolic Syndrome, 15
  • [6] Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective study
    Hajika, Yuriko
    Kawaguchi, Yuji
    Hamazaki, Kenji
    Kumeda, Yasuro
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [7] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
    Ramanan, Ezhil Arasan
    Ravi, Sailatha
    Anbu, K. R. Radha
    Michael, Margaret
    DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [8] Evaluation of efficacy and safety of Lascufloxacin tablet for Nursing and healthcareassociated pneumonia: Single-arm, open-label clinical trial
    Hosogaya, Naoki
    Takazono, Takahiro
    Ota, Kenji
    Ito, Yuta
    Ashizawa, Nobuyuki
    Takeda, Kazuaki
    Iwanaga, Naoki
    Yoshino, Yukari
    Ishikawa, Yasuyuki
    Izumikawa, Koichi
    Yatera, Kazuhiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    RESPIROLOGY, 2023, 28 : 204 - 205
  • [9] Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients
    Heo, Kyoung
    Lee, Byung In
    Do Yi, Sang
    Huh, Kyoon
    Kim, Jae Moon
    Lee, Sang Ahm
    Shin, Dong Jin
    Song, Hong Ki
    Lee, Sang Kun
    Kim, Jeong Yeon
    Lu, Sarah
    Dubois, Cecilia
    Tonner, Francoise
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (05): : 402 - 409
  • [10] Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study
    Sadayoshi Ito
    Naoki Kashihara
    Kenichi Shikata
    Masaomi Nangaku
    Takashi Wada
    Yasuyuki Okuda
    Tomoko Sawanobori
    Clinical and Experimental Nephrology, 2021, 25 : 1070 - 1078
12345